Investor Presentation FY22
Filed with ASX · · 19 pages · English
In the deck
Story so far
Earlier from Nova Eye Medical
- Appendix 4E and Annual Report FY22
- Glaucoma Sales update
- iTrack Advance Commercial Roll-Out Commenced
- AlphaRet Investor Presentation
- 2RT Pivotal Study and Regulatory Pathway
Later from Nova Eye Medical
- Clarification Glaucoma Surgical Devices Sales Update
- AGM presentation 2022
- Status of MArket Clearance for iTrack Advance in the USA
- Glaucoma Surgical Devices Sales Update
- Suspension from Official Quotation
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical